Shares are up 7c or 1.09% in after market trading to $6.50 per share, after indicating to investors earlier that a reduction in workforce of approximately 22% was in the works, resulting in an IGM extension of its cash runway into the second quarter of 2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IGMS:
- IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
- IGM Biosciences price target lowered to $11 from $17 at H.C. Wainwright
- IGM Biosciences price target lowered to $16 from $19 at Wedbush
- IGM Biosciences price target lowered to $25 from $26 at Stifel
- IGM Biosciences price target lowered to $8 from $11 at RBC Capital